Pneumocystis carinji is an extracellular organism which is thought to require attachment to alveolar epithelial cells for its growth and replication in humans. Fibronectin (Fn) binding to P. carinji is essential for optimal P. carinfi attachment. This study demonstrates that gp120, a 110-120-kD membrane glycoprotein on P. carinji, mediates attachment of the organism to cultured lung cells and is the site of Fn binding to P. carinji. A "Cr-labeled P. carinfi binding assay was used to quantify attachment of the organism to the alveolar epithelial cell line A549. Addition of free gpl20, purified from whole P. carinji organisms, caused a significant decrease in attachment of P. carinti to A549 cells from 44.2±5.5% to 22.4±4.2% (P < 0.01). Preincubation of the P. carinii organisms with a polyclonal antibody to gpl20 also resulted in a marked decrease in P. carinji attachment to A549 cells from 46.8%±5.2% to 213±4.8% (P < 0.01). Furthermore, addition of free gp120 to P. carinfi organisms caused a significant reduction in specific binding of 125I-Fn to P. carinli (from 83.3±8.5 ng to 47.1±5.9 ng, P < 0.01). Similarly, anti-gpl20 antibody decreased specific Fn binding to P. carinfi from 74.3±8.4 ng to 25.5±5.3 ng (P < 0.001). Solubilized P. carriim organisms separated by gel electrophoresis and blotted with "'I-Fn demonstrated specific binding of the '2'I-Fn to gpl20. In addition, a specific anti-#,-integrin antiserum reacted with gpl20 by Western blot, suggesting structural homology between gpl20 and the t-subunit of integrins. Thus, the data suggest that the P. carinii membrane glycoprotein gpl20 functions as a Fn binding protein and is required for optimal P. carinji attachment to alveolar epithelial cells. (J. Clin. Invest. 1991. 88:403-407.)
Introduction
Pneumocystis carinii pneumonia is a major cause ofmorbidity and mortality in immunosuppressed patients (1, 2) . Current concepts suggest P. carinji is exclusively an extracellular parasite dependent upon attachment to alveolar cells for growth and replication of the organism (3, 4) . Ultrastructural studies indicate the organism attaches to host cells by a process involving apposition but Receivedfor publication 16 October 1990 and in revisedform 15 March 1991.
branes (3) (4) (5) (6) (7) . P. carinii organisms have been noted to bind preferentially to type I alveolar epithelial cells (3, (5) (6) (7) , although attachment to type II cells has been occasionally detected (5) .
Recent investigations into the cellular components of P. carinji have demonstrated the presence of a P. carinii-specific 1 10-120-kD surface glycoprotein (8) (9) (10) (11) (12) , termed gpl20 by Radding et al. (1 1). P. carinji gpl2O is a highly glycosylated molecule containing mannose and n-acetyl-glucosamine residues (9, 12) . The large bandwidth of gpl2O observed on gel electrophoresis has been attributed to differential glycosylation of the protein component of the antigen (10) . The exact structure and protein sequence of this molecule (gp 120) have yet to be determined. The specific role ofgp 120 in the pathogenesis of P. carinii infection is also unknown.
This study examined the hypothesis that gpl20 on the surface ofP. carinii mediates attachment ofthe organism to alveolar epithelial cells. Previous work from our laboratory (13) has demonstrated that the cell-adhesive glycoprotein fibronectin (Fn)' binds to P. carinji organisms and is necessary for the optimal attachment of P. carinii to the alveolar epithelial cell line, A549. The results of this study indicate that gp 12O is the site of Fn binding on P. carinji and that gp120, at least in part, is responsible for the attachment of the organism to the alveolar epithelium.
Methods
Isolation ofPneumocystis carinii. P. carinii pneumonia was induced in pathogen-free rats by immunosuppression with dexamethasone and transtracheal inoculation of P. carinii organisms as described by Bartlett et al. (14) . P. cariniitrophozoites were harvested 4-6 wk after inoculation when the rats were moribund with P. carinii pneumonia. Rats were killed by intraperitoneal injection of T-61 Euthanasia Solution (Taylor Pharmacal Co., Decatur, IL), and the trachea was cannulated following a mid-line neck incision. The lungs were lavaged X 6 with 8-ml aliquots ofHBSS plus 0.6 mM EDTA, penicillin 100 U/ml, streptomycin 100 Ag/ml, gentamicin 4 gg/ml, and amphotericin B 0.5 ug/ ml (lavage solution). Approximately 40-45 ml of lavage fluid was obtained from each rat.
P. carinii were purified by a method adapted from Masur (15) . The lavage fluid was centrifuged (400 g X 10 min) to pellet inflammatory and alveolar cells, and the supernatant was saved. The pellet was resuspended in lavage solution to prepare cytopreparation smears (Cytospin II; Shandon Southern Instruments Inc., Sewickley, PA). The presence ofP. carinii cysts and trophozoites was verified using Gomori methenamine silver stain (16) and Diff-Quik stain (Difco Laboratories Detroit, MI) (17) . To obtain highly purified populations of P. carinii trophozoites, the supernatants were centrifuged (1,800 g x 30 min), resuspended in 1 ml of lavage solution and trophozoites quantified by the method of Bartlett et al. (18) . Examination of the trophozoite suspen-sion showed that P. carini organisms represented 97-99% of intact cellular material in the suspension. Any samples containing bacterial, fungal, or inflammatory cell contamination were discarded.
Purification ofP. carinii gpl20. P. cariniigpl20 was purified by two separate methods. In the first technique, purified P. carinii trophozoite preparations were solubilized in a reducing SDS-PAGE sample buffer (0.125 M Tris, 4% SDS, 0.002% bromphenol blue, 20% glycerol, and 4% 2-mercaptoethanol). P. carinii antigens were separated by SDS-PAGE (Mini Protean II; Bio-Rad Laboratories, Richmond, CA) according to the method of Laemmli (19). To obtain a purified sample of the P. carinhi membrane glycoprotein gpl20, bands between 110 and 120 kD were cut from the gels and the protein was electroeluted (model 422 Electroeluter; Bio-Rad) from the gel. A sample ofthe freshly eluted P. carinii gp120 was placed in SDS-PAGE sample buffer and gels were repeated running the gp 120 alongside the whole P. carinii preparations to verify the purity ofthe preparation. The second method for purification of P. carinji gp 120 was performed by separation of solubilized P. carinji antigens by HPLC on a sizing column (TSK 3000 SW; Beckman Instruments, San Ramon, CA). Fractions corresponding to gp 120 were collected and their purity verified by two-dimensional gel chromatography as described by O'Farrell (20) . To prepare gp 120 for use in cell culture experiments, the gp 120 solutions were concentrated and transferred to HBSS using a centrifugal concentrator (Centricon 30; Amicon Corp., Danvers, MA).
Development ofpolyclonal anti-gpJ20 antibodies. Polyclonal antibodies to P. carinii gpl2O were raised in New Zealand White rabbits (Johnson Rabbit Ranch, Mooresville, IN) by repeated intramuscular injection of eluted gpl20. After the third inoculation, serum collected from one of the rabbits reacted with gpl20 at a titer of 1: 10,000 by Western blot, and demonstrated no cross-reactivity with normal rat lung antigens. Serum from this animal was used for all subsequent experiments.
P. carinii attachment assay. As previously described (13, 21) , P. carinii attachment to an alveolar epithelial cell line was quantified using 5"Cr-labeled P. carinii organisms. Freshly isolated P. carinii trophozoites were incubated for 18 h in 2 ml of DME containing 0.5 ml of FCS and 50 MCi of 5"Cr sodium chromate (New England Nuclear, Boston, MA). After incubation the 51Cr-labeled P. carinii suspension was centrifuged (1,400 g X 15 min), the supernatant discarded, and the pellet resuspended in DME. The P. carinii suspension was washed X 4 to remove unincorporated 5"Cr and resuspended in DME at a concentration of 20 x 106/ml.
An alveolar epithelial cell line, A549 (CCL #185; American Type Culture Collection, Rockville, MD), was used as the target cell population for P. carinii adherence studies. A549 cells were grown to confluency in DME + 10% FCS on 24-well tissue culture dishes. Before the attachment assay, the A549 cells were washed X 2 with 1 ml ofDME to remove serum. 2 x 106 51Cr-labeled trophozoites were added to each well of A549 cells and incubated at 370C for 4 h. After the incubation, the media that contained nonadherent trophozoites were removed and saved. The cell monolayer, containing bound trophozoites, was disrupted using 10% Triton X-100 (Sigma Chemical Co., St. Louis, MO) and saved. 51Cr-labeled P. carinii organisms were quantified in each fraction (5500 gamma counter; Beckman Instruments, Inc., Berkeley, CA) and percent attachment expressed as follows: % attachment = (A/A + B) X 100, where A = 51Cr-labeled P. carinii bound to the A549 monolayer and B = 5"Cr-labeled P. carinii free in the media.
To determine the effect of soluble gpl20 on P. carinii attachment, the assay was performed as above with the addition of0.5, 5, 50,500, or 5,000 ng/ml of purified gpl2O. Control experiments using electroeluted albumin purified in a similar manner were also performed. To quantify the effect of the anti-gpl20 antibody on attachment, 51Cr-labeled P. carinii were preincubated with the anti-gpl20 for 1 h and then added to the A549 cell monolayer. Control experiments were conducted using pooled rabbit serum and polyclonal rabbit IgG.
25I-Fn binding to P. carinii. P. carinii trophozoites were incubated for 18 h in DME supplemented with glutamine 0.6 mg/ml, penicillin 100 U/ml, streptomycin 100 ,g/ml, amphotericin B 0.5 Mug/ml, gentamicin 4 ,ug/ml, and 0.6 mM EDTA. 1251-Fn (ICN Pharmaceuticals, Inc., Irvine, CA) binding to P. carinii was quantified as previously described (13) . Following the 18-h incubation, the P. carinii suspension was centrifuged (1,600 g X 15 min), the supernatant discarded, and the P. carinii-rich pellet was resuspended in DME at 20 X 106/ml. Reaction mixtures containing 4 X 106 P. carinii, 3 sg 1251I-Fn, and sample buffer (0.02 M Hepes and 1 mg/ml BSA in 0. 15 M NaCl at pH 7.4) to a total vol of 1 ml were incubated for 1 h. Mixtures were centrifuged (3,000 g x 2 min) to pellet trophozoites, the supernatant was removed and saved, and the pellet was resuspended in 0.5 ml of sample buffer. Following a second centrifugation, the supernatant was again saved and added to the first supernatant. '25I-Fn in the pellet (bound) and in the supernatant (free) were quantified (5500 gamma-counter; Beckman). Specific 
Results
Initial studies resulted in the isolation and purification of P. carindi gpl20 and production of a specific polyclonal antigpl20 antibody. The purity of the isolated gpl20 was assessed by both one-dimensional SDS-PAGE (Fig. 1) and two-dimensional electrophoresis (Fig. 2) . The electroeluted sample of gpl 20 resolved into both a major band at 120 kD and a very small band at 50-55 kD. Both bands reacted with the antigp 120 antibody by Western blot in the eluted gp 120 solution as well as in the P. carinii organism lysate (Fig. 1) . The gpl2O purified by HPLC did not appear to contain the 55-60 kD component on either isoelectric focusing (Fig. 2) tion from the original gel or by HPLC. SDS-PAGE of the eluted gp 120 (lane 2) demonstrated both gpl20 and another small band at 55-60 kD. A Western blot of solubilized whole P. carini antigens (lane 3), the eluted gp 120 (lane 4), and HPLC purified gpl20 (lane 5) using polyclonal antigpl20 demonstrated specific binding to both the gpl20 and the 55-60-kD antigen in the whole P. carindi and eluted gp 120 preparations, while the anti-gpl20 bound only to the 120-kD band present in the HPLC purified gpl 20. blot with the anti-gp120 antibody (Fig. 1 ). This suggests that the 50-55-kD band in the P. carinji lysate and in the eluted gpl20 solution either shares similarly reactive epitopes or, more likely, is actually derived from degradation of the intact gpl20 molecule.
Addition of eluted gpl 20 to the 5"Cr-labeled P. carinji attachment assay resulted in a significant, concentration-dependent decrease in P. carinji attachment (Fig. 3) . This effect was maximum at 500 ng/ml (4 nM) which reduced attachment from 44.2±5.5% to 22.4±4.2% (P < 0.01), but persisted to concentrations as low as 20 ng/ml (0.16 nM). Release of31Cr by P. carinii, a sensitive marker of cellular injury (24), was not increased after the exposure of P. carinji to gpl20. The HPLCpurified gpl20 was an equipotent inhibitor ofP. carinii attachment to A549 cells, indicating that the small quantity of50-55-kD contaminant in the eluted gpl20 solution did not contribute to its effects on P. carinii attachment. There was no evidence ofdisruption ofthe A549 cell monolayer during the 4 h of the attachment assay. Heat inactivation ofgpl20 (100I C X 5 min) eliminated the effect of gpl2O on P. carinii attachment (Fig. 3) . Control proteins eluted from polyacrylamide gels and purified in the same manner did not alter P. carinii attachment (data not shown).
The polyclonal anti-gp 120 antibody was similarly examined for its effect on P. carinji attachment. As demonstrated for soluble gpl20, anti-gp 120 caused a significant, concentration- dependent decrease in P. carinii attachment (Fig. 4) . Control rabbit sera or polyclonal rabbit IgG solutions did not affect P. carinii attachment to A549 cells. These data suggest that one function of gp 120 may be to promote attachment ofP. carinii to alveolar epithelial cells.
To evaluate the mechanism for the decrease in P. carinii attachment observed, the effects of soluble gpl20 and antigpl20 on 1251I-Fn binding to P. carinii organisms were assayed.
Previous work from our laboratory has demonstrated that Fn binding to P. carinji organisms is a saturable and specific process that is essential for optimal P. carinii attachment (13) .
Addition ofeluted gp 120 produced a concentration-dependent decrease in 1251-Fn binding to P. carinii (Fig. 5) . The maximum inhibition of 1251-Fn binding was caused by a gpl20 concentration of 500 ng/ml, a concentration which also caused the greatest reduction in P. carinii attachment to A549 cells. The HPLC-purified gpl 20 solution had a similar effect on 125I-Fn binding to P. carinii. Control eluted proteins had no effect on '25I-Fn binding to P. carinii organisms.
The anti-gp 120 antibody also produced a marked decrease in specific 125I-Fn binding to P. carinii (Fig. 6 ) reaching its maximal effect at a 1:64 dilution. Control rabbit sera did not significantly alter 125I-Fn binding to P. carinii. Therefore, it appears that the inhibition of P. carinii attachment to alveolar epithelial cells by gpl20 and anti-gpl 20 may be due to their effects on Fn binding to the P. carinii organism.
To further examine the interaction between gpl20 and Fn, P. carinii antigens separated by SDS-PAGE were blotted with i25I-Fn. The autoradiogram demonstrated binding of 125I-Fn to gpl20 alone (Fig. 7) , which provides direct evidence that gpl20 acts as a specific binding site for Fn on the P. carinii organism. Previous characterization ofFn binding to P. carinii organisms had illustrated the binding was mediated by the RGD cell bind- Fn. Binding of 125I-Fn to P. carinji was subsequently measured after the addition of soluble P. carinli gp120. Results are expressed as mean±SEM. *P < 0.01.
ing site on the Fn molecule (13) . Addition ofa synthetic RGDS tetrapeptide effectively decreased the binding of 125I-Fn to gpl2O (Fig. 8) . This suggests the Fn binding site on P. carinji may be similar to the Fn binding site present on integrins (25, 26). To determine whether gpl20 displayed structural homology with known integrins, a Western blot ofP. carinii antigens with a specific anti-#3-integrin antiserum was performed. The Western blot exhibited binding of the anti-f,-integrin antiserum to gpl2O alone among the P. carinli antigens (Fig. 7) . Thus, gpl2O is an RGD-dependent Fn binding protein that appears to bear structural similarities to one subunit of the integrins.
Discussion
The attachment of P. carinli to alveolar epithelial cells is thought to be required for the development of subsequent infection. These data provide the first information regarding the role ofP. carinii gpl20 in attachment ofP. carinji organisms to alveolar epithelial cells. Both soluble gpl20 and anti-gp 120 antibodies caused a significant decrease in P. carinii attachment to A549 cells, and also markedly reduced specific binding ofFn to the organism. Furthermore, gpl2O was the only apparent site of Fn binding in solubilized P. carinii preparations.
Attachment of pathogenic organisms to host cells is a critical initial step in the development of many infections (27, 28) . Many pathogens exhibit specific attachment antigens or factors on their cell surface, which may act either by attaching directly to host cells (29) or by binding to host-derived cell-adhesive proteins and using these proteins as a bridge for attachment to host cells (30) . Fibronectin, an extracellular matrix protein known to mediate cell attachment (31, 32) , has been demonstrated to aid in the adherence of many organisms, including Fn binding to gpl 20. 406 attachment of the organism to alveolar cells. However, it is clear from these studies that P. carini organisms likely possess other mechanisms for attachment to host cells, as inhibition of gpl20 mediated attachment did not completely abolish P. carinm attachment.
Integrins are membrane spanning proteins made up of distinct a and :3 subunits that function as cellular receptors for extracellular matrix molecules. Integrins, by providing a link between the cellular cytoskeleton and the extracellular matrix, are essential components in cell-cell and cell-matrix attachment. The ,8-subunits ofthe integrins are highly conserved with similarly structured molecules present on insect (38) , avian (39) , and human cells (39) . A recent report of binding of an anti-fl3-integrin antibody to an uncharacterized 95-kD antigen on Candida albicans (23) extends the range of organisms on which integrin-like molecules may be present. Our data which demonstrate binding of anti-#, -integrin to P. carini gp 120 provide further possible evidence for the evolutionary conservation of this molecule. Future studies to determine the amino acid sequence of gpl20 will permit a direct comparison between the structures of gpl2O and fll-integrin.
The role of P. carini antigens in the attachment of P. carinm to alveolar epithelial cells has not been previously investigated. Our data suggest that the P. carini membrane glycoprotein gpl2O functions as a Fn binding protein and mediates attachment ofthe organism to alveolar cells, an essential initial step in the development ofP. carini infection. Further investigation into the mechanism ofP. carini attachment may lead to the development of novel therapeutic strategies to block attachment of the organism and thereby reduce the incidence of this often fatal disease.
